Drug Shortage Report for BEPREVE
| Report ID | 103041 |
| Drug Identification Number | 02456532 |
| Brand name | BEPREVE |
| Common or Proper name | BEPREVE |
| Company Name | BAUSCH & LOMB INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BEPOTASTINE BESILATE |
| Strength(s) | 1.5% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 10ml |
| ATC code | S01 |
| ATC description | L3 not assigned |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2019-11-15 |
| Estimated end date | |
| Actual end date | 2020-02-11 |
| Shortage status | Resolved |
| Updated date | 2020-02-14 |
| Company comments | artwork issue |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-02-14 | French | Compare |
| v3 | 2020-02-14 | English | Compare |
| v2 | 2020-01-10 | French | Compare |
| v1 | 2020-01-10 | English | Compare |
Showing 1 to 4 of 4